Consideration of a bone marrow transplant (BMT) for a child with a genetic disease depends upon many factors including the pathophysiology of the disorder, the natural history of the disease, whether an alternative therapy exists and whether a donor is available. Children with disorders such as seve
Storage and transplantation of bone marrow in the treatment of malignant diseases
β Scribed by Theodore I. Malinin
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- English
- Weight
- 368 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The development of special methods of bone marrow transplantation, coupled with new knowledge in the area of donorβrecipient selection and the suppression of the secondary diseases, has generated renewed interest in allografting of bone marrow for a variety of diseases. The interest in marrow allotransplantation has overshadowed previously existing interest in autotransplantation despite the fact that autotransplantation has not met with serious side effects, such as GVH and secondary diseases.
Sufficient evidence demonstrating the reliability of methods of shortβterm and longβterm storage of human bone marrow has now been accumulated. It can be anticipated that reinfusion of bone marrow stored by these methods will result in uniform hematopoetic recovery of bone marrow suppressed by irradiation or chemotherapeutic agents. In cases of malignant diseases in anticipation of future needs, diseaseβfree marrow can be collected before the malignant process becomes generalized. Since bone marrow is best obtained under general anesthesia, routine bone marrow collection and storage from patients undergoing surgery for specific malignancies is suggested.
π SIMILAR VOLUMES
Nineteen patients with advanced malignant tumors, less than 20 years old were treated with intensive chemotherapy (vincristine 2 mg/m2 i.v. and adriamycin 60 mg/m2 i.v. on day - 7; cyclophosphamide 45 mg/kg i.v. on days -6 to -3), total body irradiation (TBI, 600 rads on day -1) and autologous bone
A 32-year-old woman developed acute monocytic leukemia within a year of treatment for Hodgkin's disease with chemotherapy and radiation. Residual leukemia was present in the bone marrow after two induction courses of high-dose Ara-C. She received a bone marrow transplant from an HLA- and DR-identica
"PVP storage disease" is a disorder occurring in patients who have received high molecular weight polyvinylpyrrolidone (PVP), which cannot be excreted from the body. These large polymers deposit in the histiocytes and cause proliferation and infiltration of histiocytes in the reticuloendothelial sys